Day: February 27, 2024

VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) announces that Hayden Locke, President & CEO, will be presenting at the 2024 BMO Global Metals, Mining and Critical Minerals Conference on Tuesday, February 27th 2024 at 5:00pm Eastern Time. The presentation will highlight the Company’s progress at the Marimaca Project toward the Definitive Feasibility Study as well as the Company’s regional exploration strategy. A live stream of the presentation will be available at the link below. Webcast Link (Tuesday, February 27th, 2024, 5:00pm ET) Contact InformationFor further information please visit www.marimaca.com or contact: Tavistock +44 (0) 207 920 3150Emily Moss / Adam Baynesmarimaca@tavistock.co.uk Forward Looking Statements This news release...

REDWOOD CITY, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will present a company overview at the TD Cowen 44th Annual Healthcare Conference on Tuesday, Mar. 5, at 2:50 p.m. EDT (11:50 a.m. PDT) in Boston, Massachusetts. A live webcast of the presentation will be available on the Events and Presentations page of Bolt’s website at www.boltbio.com. Archived replays will be available for 30 days following the event. About Bolt Biotherapeutics, Inc.Bolt Biotherapeutics is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Bolt Biotherapeutics’ pipeline candidates are built on the Company’s deep expertise in myeloid...

6,424 hectare Dufferin Project located approximately 130km northwest of the Key Lake Mines, SaskatchewanFigure 1Project Map reflecting the results of certain historic exploration work on the Project and in the Project area. This information was gathered from historic exploration work conducted on the Project, including from SMDI descriptions and assessment reports filed with the Saskatchewan Governments. The Company has not had a qualified person independently verify this information. Information regarding exploration work in the Project area is not necessarily indicative of the mineralization (if any) present at the Project.VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — Refined Metals Corp. (CSE: RMC; OTC: RFMCF; FRA: CWA0) (the “Company”) is pleased to announce that it has entered into an option agreement...

VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA” or the “Company”), holder of the largest uranium exploration portfolio in two of the highest-grade uranium districts in the world, is pleased to announce that it has appointed Ryan Gaffney as Senior Vice President, Business Development of the Company, effective February 26, 2023. Troy Boisjoli, CEO of ATHA commented, “We are very fortunate to welcome Mr. Gaffney and his decades of capital markets and resource experience to the ATHA team, as we continue to place an emphasis on putting together a world-class team of experienced professionals. Looking ahead, we believe ATHA’s dominant land position in multiple high-grade uranium basins allows us to execute ATHA’s exploration and development strategy from a...

Government incentives are a critical part of supporting job growth in advanced manufacturing and other important global technologies Justin, TX, Feb. 27, 2024 (GLOBE NEWSWIRE) — Justin, TX – (February 27, 2024) – Canoo Technologies (NASDAQ:  GOEV), a leading high-tech advanced mobility company, announced it has received its first funding from the State of Oklahoma for successfully achieving an employment milestone from previously announced agreements awarded on workforce and economic development incentives from the state of Oklahoma.   The state is now home to over 20% of Canoo’s total workforce. “We selected the state of Oklahoma as our manufacturing home due to the state’s strong support and hardworking employees.  We are very proud to reach this first hiring milestone and excited to bring high paying advanced manufacturing jobs...

NT219 was well tolerated Anti-tumor activity at relevant higher dose levels observed with 29% Objective Response Rate (ORR) and 71% Disease Control Rate (DCR) REHOVOT, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) —   Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced clinical results from its Phase 1/2 dose escalation study of NT219 in combination with cetuximab in the treatment of patients with recurrent/metastatic head and neck cancer (R/M SCCHN). The data were presented at the European Society of Medical Oncology Targeted Anticancer Therapies (ESMO TAT) Congress 2024 in Paris on Monday, February 26,...

MURRAY, Utah, Feb. 27, 2024 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months and year ended December 31, 2023. Fourth Quarter 2023 Results:Revenue of $575.1 million, up $41.8 million or 7.8% compared to the same period last year GAAP net income of $1.4 million, compared to a net loss of $36.6 million in the same period last year Adjusted EBITDA of $167.7 million, up $42.1 million or 33.5% compared to the same period last yearFull Year 2023 Results:Revenue of $2,254.2 million, up $447.8 million or 24.8% compared to 2022 GAAP net income of $3.3 million, compared to net loss...

CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the 2024 TD Cowen Health Care Conference on Tuesday, March 5, 2024 at 9:10 a.m. ET in Boston. A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be available there for 30 days following the event. About Generation Bio    Generation Bio is innovating non-viral genetic medicines to provide durable and redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The company is developing two distinct and complementary platforms:...

Addition of Omanpe License Increases Size of the Enchi Gold Project to 248 km² VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — Newcore Gold Ltd. (“Newcore” or the “Company”) (TSX-V: NCAU, OTCQX: NCAUF) is pleased to announce several positive developments at the Company’s 100%-owned Enchi Gold Project (“Enchi” or the “Project”) in Ghana. Newcore has increased the size of its district scale Project with the addition of the Omanpe license. Omanpe covers 32.12 km² and grows the size of the Enchi Gold Project to 248 km². In addition, Newcore has completed an updated Environmental and Social Baseline Study for the Project (the “2023 Baseline Study” or the “Study”), an important milestone in continuing to de-risk and advance the Project towards production....